Unlock stock picks and a broker-level newsfeed that powers Wall Street.

Berlin - Delayed Quote EUR

Northwest Biotherapeutics Inc (NBYB.BE)

0.2840
0.0000
(0.00%)
As of August 13 at 9:12:04 AM GMT+2. Market Open.
Loading Chart for NBYB.BE
  • Previous Close 0.2840
  • Open 0.2840
  • Bid --
  • Ask --
  • Day's Range 0.2840 - 0.2840
  • 52 Week Range 0.2760 - 0.4840
  • Volume 1,300
  • Avg. Volume 0
  • Market Cap (intraday) --
  • Beta (5Y Monthly) --
  • PE Ratio (TTM) --
  • EPS (TTM) --
  • Earnings Date May 8, 2025 - May 12, 2025
  • Forward Dividend & Yield --
  • Ex-Dividend Date --
  • 1y Target Est --

Recent News: NBYB.BE

View More

Performance Overview: NBYB.BE

Trailing total returns as of 5/6/2025, which may include dividends or other distributions. Benchmark is S&P 500 (^GSPC) .

YTD Return

NBYB.BE
0.00%
S&P 500 (^GSPC)
4.67%

1-Year Return

NBYB.BE
33.02%
S&P 500 (^GSPC)
8.23%

3-Year Return

NBYB.BE
96.35%
S&P 500 (^GSPC)
35.98%

5-Year Return

NBYB.BE
96.35%
S&P 500 (^GSPC)
96.84%

Compare To: NBYB.BE

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: NBYB.BE

View More

Valuation Measures

As of 5/5/2025
  • Market Cap

    358.91M

  • Enterprise Value

    416.66M

  • Trailing P/E

    --

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    218.77

  • Price/Book (mrq)

    --

  • Enterprise Value/Revenue

    263.39

  • Enterprise Value/EBITDA

    --

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    --

  • Return on Assets (ttm)

    --

  • Return on Equity (ttm)

    --

  • Revenue (ttm)

    --

  • Net Income Avi to Common (ttm)

    --

  • Diluted EPS (ttm)

    --

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    --

  • Total Debt/Equity (mrq)

    --

  • Levered Free Cash Flow (ttm)

    --

Research Analysis: NBYB.BE

View More